BR9914491A - Processo para produção de uma proteìna de superfamìlia de imunoglobulina funcional - Google Patents

Processo para produção de uma proteìna de superfamìlia de imunoglobulina funcional

Info

Publication number
BR9914491A
BR9914491A BR9914491-3A BR9914491A BR9914491A BR 9914491 A BR9914491 A BR 9914491A BR 9914491 A BR9914491 A BR 9914491A BR 9914491 A BR9914491 A BR 9914491A
Authority
BR
Brazil
Prior art keywords
protein
immunoglobulin
cell
functional
mhc class
Prior art date
Application number
BR9914491-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Lars Ostergaard Pedersen
Soren Buus
Original Assignee
Lars Ostergaard Pedersen
Soren Buus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lars Ostergaard Pedersen, Soren Buus filed Critical Lars Ostergaard Pedersen
Publication of BR9914491A publication Critical patent/BR9914491A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR9914491-3A 1998-09-14 1999-09-14 Processo para produção de uma proteìna de superfamìlia de imunoglobulina funcional BR9914491A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801155 1998-09-14
PCT/DK1999/000484 WO2000015665A2 (en) 1998-09-14 1999-09-14 A method of producing a functional immunoglobulin superfamily protein

Publications (1)

Publication Number Publication Date
BR9914491A true BR9914491A (pt) 2002-01-15

Family

ID=8101632

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914491-3A BR9914491A (pt) 1998-09-14 1999-09-14 Processo para produção de uma proteìna de superfamìlia de imunoglobulina funcional

Country Status (10)

Country Link
EP (1) EP1114063A2 (ja)
JP (1) JP2002524104A (ja)
KR (1) KR20010075108A (ja)
CN (1) CN1326466A (ja)
AU (1) AU771239C (ja)
BR (1) BR9914491A (ja)
CA (1) CA2343313A1 (ja)
MX (1) MXPA01002674A (ja)
NZ (1) NZ511031A (ja)
WO (1) WO2000015665A2 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2440773A1 (en) 2001-03-14 2002-09-19 Dakocytomation Denmark A/S Novel mhc molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of mhc molecules
AU2003223936A1 (en) * 2002-05-17 2003-12-02 Kobenhavns Universitet Method for purifying denatured proteins having a desired disulfide bond configuration
US20040072262A1 (en) * 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
WO2004072112A2 (en) * 2003-02-11 2004-08-26 Københavns Universitet A method for formulating mhc-like molecules for long time storage
JP2007526761A (ja) * 2003-10-31 2007-09-20 ヴィタテックス， インコーポレイテッド 循環性の腫瘍細胞および内皮細胞の検出のための血液試験のプロトタイプおよび方法
EP1781313A4 (en) 2004-06-17 2009-08-26 Beckman Coulter Inc MYCOBACTERIUM TUBERCULOSIS EPITOPES AND METHODS OF USE
AU2005277227B2 (en) * 2004-08-19 2011-10-06 Biogen Ma Inc. Refolding transforming growth factor beta family proteins
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
CL2007002225A1 (es) * 2006-08-03 2008-04-18 Astrazeneca Ab Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
EP2361930A3 (en) 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
JP5583005B2 (ja) 2007-05-01 2014-09-03 バイオジェン・アイデック・エムエイ・インコーポレイテッド 血管新生を増大させるための組成物および方法
EP2167536A1 (en) 2007-07-03 2010-03-31 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
US20090053786A1 (en) 2007-07-09 2009-02-26 Yung-Hsiang Kao Prevention of disulfide bond reduction during recombinant production of polypeptides
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
CN103364558A (zh) * 2013-07-17 2013-10-23 江阴泽成生物技术有限公司 一种人肿瘤标志物癌胚抗原（cea）的磁微粒化学发光免疫分析试剂盒及其检测方法
CN109402036A (zh) * 2018-11-07 2019-03-01 河北科技师范学院 牛源肠炎沙门菌trxB基因缺失的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
EP0640094A1 (en) * 1992-04-24 1995-03-01 The Board Of Regents, The University Of Texas System Recombinant production of immunoglobulin-like domains in prokaryotic cells
AU4923593A (en) * 1992-09-15 1994-04-12 Rockefeller University, The Major histocompatibility complex molecules and modifications thereof
EP0726777A4 (en) * 1993-10-25 2002-04-24 Anergen Inc Procarciotic expression of MHC proteins
AU3036597A (en) * 1996-05-21 1997-12-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells

Also Published As

Publication number Publication date
WO2000015665A3 (en) 2000-08-17
EP1114063A2 (en) 2001-07-11
NZ511031A (en) 2003-11-28
KR20010075108A (ko) 2001-08-09
MXPA01002674A (es) 2002-06-04
AU771239C (en) 2004-10-14
WO2000015665A2 (en) 2000-03-23
JP2002524104A (ja) 2002-08-06
AU5504799A (en) 2000-04-03
CA2343313A1 (en) 2000-03-23
AU771239B2 (en) 2004-03-18
CN1326466A (zh) 2001-12-12

Similar Documents

Publication Publication Date Title
BR9914491A (pt) Processo para produção de uma proteìna de superfamìlia de imunoglobulina funcional
Morita et al. Functionally distinct subsets of human γ/δ T cells
Cooper et al. A novel cell surface molecule on early B-lineage cells
Mannu et al. Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in beta-thalassemia intermedia erythrocytes
Davis Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response
Dellabona et al. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8-T cells.
CN103797028B (zh) 使靶细胞可逆染色的方法
Parham Monoclonal antibodies against two separate alloantigenic sites of HLA-1340
Goding Allotypes of IgM and IgD receptors in the mouse: a probe for lymphocyte differentiation
Cook et al. Structural Studies on the Murine Ia Alloantigens: II. Molecular Qeight Characterization of the Products of the IA and IE/C Subregions
FI85946B (fi) Foerfarande foer framstaellning av en bispecifik antikropp och bestaemningsfoerfarande varvid denna anvaends.
Andrew et al. Engineered cupredoxins and bacterial cytochrome c oxidases have similar CuA sites: Evidence from resonance Raman spectroscopy
Zetina et al. Kinetics of renaturation and self-assembly of intermediates on the pathway of folding of the β2-subunit of Escherichia coli tryptophan-synthetase
Sim et al. Innate receptors with high specificity for HLA class I–peptide complexes
Gazit et al. Alloantigens of the human T (HT) genetic region of the HLA linkage group
Murayama et al. Epitope expression on primate lymphocyte surface antigens
Zola Monoclonal antibodies against human cell membrane antigens: A review
Paletta et al. The hypervariable region 4 (HV4) and position 93 of the α chain modulate CD1d‐glycolipid binding of iNKT TCRs
Bettinardi et al. Analysis of amplified T cell receptor Vβ transcripts by a non-isotopic immunoassay
Navarrete Human leucocyte antigens
Halloran et al. The specificity and significance of the inhibition of Fc receptor binding by anti H-2 sera
Dickler et al. B-lymphocyte Fc receptor-associated non-H-2 antigens are determined by a single polymorphic locus which is linked of the Mls locus
De Vries et al. The role of target cells, monocytes, and Fc receptor-bearing lymphocytes in human spontaneous cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity
Boyd et al. Monoclonal rat anti-MHC alloantibodies detect HLA-linked polymorphisms in humans
Dubiski et al. Cross-reaction of a monoclonal antibody to human MHC class II molecules with rabbit B cells

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.